Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Diabetes
100%
Patient
69%
Maturity Onset Diabetes of the Young
58%
Prostate Cancer
57%
Hemoglobin A1c
54%
Diabetes Mellitus
49%
Glucose
35%
Analysis
30%
Blood Glucose
25%
Electronic Patient Record
23%
Statin
23%
Cohort Analysis
23%
Therapeutic Procedure
22%
Neoplasm
22%
Health
21%
Patient with Diabetes
20%
Prostatectomy
19%
Malignant Neoplasm
19%
Randomized Controlled Trial
18%
Inpatient
17%
Body Mass Index
17%
Development
16%
Organoid
16%
Recurrent Disease
16%
Exome Sequencing
16%
Somatic Mutation
15%
Squamous Cell Carcinoma
15%
Thyroid Cancer
14%
Outpatient
14%
Gene
14%
Diagnosis
14%
Insulin Resistance
14%
Low Density Lipoprotein Cholesterol
14%
Triacylglycerol
14%
Papillary Thyroid Cancer
13%
Hypoglycemia
13%
Physician
13%
Lung Cancer
13%
End Stage Renal Disease
13%
Adenoma
12%
Lung
12%
Cardiovascular Disease
12%
Health Care Cost
12%
Prostate Specific Antigen
12%
Blood
12%
Hospital
12%
Hazard Ratio
12%
Disease
11%
Colorectal Carcinoma
11%
Biological Marker
11%
Learning
11%
Game Addiction
11%
ACE Inhibitor
11%
Clear Cell Renal Cell Carcinoma
11%
Disease Management
11%
Breast Cancer
11%
Overall Survival
10%
Insulin
10%
High Density Lipoprotein Cholesterol
10%
Age
9%
Base
9%
Carcinogenesis
9%
Cancer Cell
9%
Tumor Microenvironment
9%
Insulin Release
9%
Chronic Disease
9%
Incidence
9%
Adult
9%
Medical Examination
8%
Proportional Hazards Model
8%
Glycemic
8%
Bladder Cancer
8%
Health Care Management
8%
Patient with Type 2 Diabetes
8%
Impaired Glucose Tolerance
8%
Stereotactic Body Radiation Therapy
8%
Cholesterol
8%
Antidiabetic Agent
8%
Neck
8%
Health Care Provider
8%
Immaturity
8%
Pathologic Myopia
8%
Stomach Carcinoma
8%
Self Esteem
8%
MHealth
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Angiotensin Receptor Antagonist
8%
Prospective Study
8%
COVID-19
8%
Prevalence
8%
Tumor Progression
8%
Association
8%
Clinical Decision Support System
7%
Follow up
7%
Prognostic Factor
7%
Cells
7%
Mortality
7%
Computer Assisted Tomography
7%
Colorectal Cancer
7%
Hyperglycemia
6%
Biochemistry, Genetics and Molecular Biology
Exome Sequencing
68%
Mutation
51%
Somatic Mutation
50%
Gene Expression Profiling
43%
Nested Gene
38%
Array Comparative Genomic Hybridization
34%
MicroRNA
32%
Copy-Number Variation
31%
Body Mass
25%
Whole Genome Sequencing
22%
Stromal Cell
22%
Cancer Cell
21%
Stem Cell
20%
Tumor-Related Gene
20%
Gene Dosage
19%
Microsatellite Instability
17%
STAT3
17%
Carcinogenesis
17%
Glucose Blood Level
16%
Single-Nucleotide Polymorphism
16%
RNA Sequencing
16%
Statin
16%
Fibroblast
16%
Somatic Mutation
16%
Germline
15%
Next Generation Sequencing
14%
Prevalence
14%
Upregulation
13%
Methylation
13%
Phosphotransferase
13%
Kinase
13%
Immunity
12%
Microsatellite
12%
KRAS
12%
Exome
12%
Tumor Progression
12%
Gene Expression
12%
Mesenchymal-Epithelial Transition
11%
Promoter Region
11%
Immunocompetent Cell
11%
Allele
11%
CD133
11%
Random Forest
11%
Oncogene
11%
Survival
11%
Candidate Gene
11%
Development
10%
Cell Cycle
10%
Cancer Cell
10%
Gene
10%
Evolution
10%
Indel
10%
Messenger RNA
9%
SPOP
9%
Chromothripsis
9%
Epigenetics
9%
Reperfusion
9%
Dynamics
9%
Epidermal Growth Factor Receptor
9%
APOBEC
8%
Cholesterol Blood Level
8%
Kinase
8%
Electric Potential
8%
Triglyceride
8%
Retrotransposon
8%
Prostate-Specific Antigen
8%
CCL2
8%
Germ Cell
8%
Growth
8%
Genetic Mechanism
7%
Genome Sequencing
7%
Cohort Study
7%
Case-Control Study
7%
Sequencing
7%
Glucose
7%
Cell Proliferation
7%
Genetics
7%
Transcription
7%
Comprehension
7%
Drug Resistance
7%
Upregulation
7%
Low Density Lipoprotein Cholesterol Level
7%
Association
7%
Cell Adhesion
7%
Classification
7%
STAT3
7%
Glycated Hemoglobin
7%
Hematopoietic Cell
6%
HDL-Cholesterol
6%
Microsatellite Instability
6%
Catenin
6%
Introspection
6%
Wnt Signaling Pathway
6%
Gene Frequency
6%
Kinesin
6%
Age
6%
Phenotype
6%
Transcriptome
6%
Tumor-Related Gene
6%
Microsatellite DNA
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
40%
Prostate Cancer
36%
Statin (Protein)
32%
Diabetes Mellitus
28%
Angiotensin Receptor Antagonist
27%
Hemoglobin A1c
27%
Cohort Study
26%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
24%
Low Density Lipoprotein Cholesterol
24%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Statin (Protein)
19%
Neoplasm
19%
Low Density Lipoprotein Cholesterol
18%
Dipeptidyl Carboxypeptidase Inhibitor
17%
Adverse Drug Reaction
17%
Pharmacovigilance
15%
Prevalence
14%
Diseases
12%
Sulfonylurea
12%
Diabetes Mellitus
12%
Acute Kidney Failure
11%
Non Insulin Dependent Diabetes Mellitus
11%
Comorbidity
11%
Angiotensin Receptor Antagonist
11%
Contract Research Organization
11%
Renal Cell Carcinoma
11%
End Stage Renal Disease
11%
Combination Therapy
10%
Thyrotropin
10%
Hyperglycemia
9%
Sodium Glucose Cotransporter 2 Inhibitor
9%
High Density Lipoprotein Cholesterol
9%
Bladder Cancer
8%
Cardiovascular Disease
8%
Squamous Cell Carcinoma
8%
Recurrent Disease
8%
Cerebrovascular Accident
8%
Triacylglycerol
7%
Hemoglobin A1c
7%
Buparlisib
7%
Atorvastatin
7%
Mortality
7%
Metabolic Syndrome X
7%
Drug Safety
7%
Pandemic
6%
Impaired Glucose Tolerance
6%
Glucose
6%
Overall Survival
6%
Prostate Specific Antigen
6%
Retrospective Study
6%
Ethanol
6%
Drug
6%
Biological Marker
6%
Disease
6%
Remission
6%
Alanine Aminotransferase
6%
Overall Survival
6%
Incidence
6%
Glycosylated Hemoglobin
6%
Recurrence Risk
6%
Heart Infarction
5%
Base
5%
Malignant Neoplasm
5%
Hepatotoxicity
5%
Side Effect
5%
Disease Exacerbation
5%
Biochemical Recurrence
5%
Urinary Tract Infection
5%
Genital Tract Infection
5%
Alanine Aminotransferase
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Monotherapy
5%
Adverse Event
5%
Atorvastatin
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Mitogen Activated Protein Kinase
5%
Drug-Drug Interaction
5%
Dapagliflozin
5%
Phosphatidylinositol 3 Kinase
5%
Dapagliflozin
5%
Imatinib
5%
Immaturity
5%
Thyroid Papillary Carcinoma
5%
Thyroid Cancer
5%
Sitagliptin
5%
Metformin
5%
Corticotropin Releasing Factor
5%
Dipeptidyl Peptidase
5%
microRNA 21
5%
Sodium Glucose Cotransporter 2
5%
Drug Repositioning
5%
Allopurinol
5%
Cetuximab
5%
Cancer Recurrence
5%
Uric Acid
5%
Hyperuricemia
5%
Brain Metastasis
5%
Hyperkalemia
5%
Hearing Impairment
5%
Drug Resistance
5%